Ilias Karaiskos INTERNIST Assistant, 1st Internal Medicine & Infectious Diseases Department

• National University of Athens, School of Medicine, Athens, Greece, 2014, Title: “Pharmacokinetic Analysis of Colistin Methanesulfonate and Colistin and Application of a Loading Dose of Colistin in Critically Ill Patients”, Grade: Excellent

• Athens Medical Association
• Hellenic Association for the control and the study of AIDS
• Hellenic Society for Infectious Diseases
• Hellenic Society for Chemotherapy
• European Society of Clinical Microbiology and Infectious Disease (ESCMID)

Editorial Boards:
AD-HOC REVIEWER for peer-reviewed international journals

• Clinical Microbiology and Infection
• Microbial Drug Resistance

• Rural Medical Center of Messini, Messinia, Greece (2000 – 2001)
• 4th Department of Internal Medicine, Athens (2005 – 2010),Senior House Officer in Internal Medicine,University School of Medicine,”Attikon”,(Professor: H. Giamarellou)
• Attending Physician in Internal Medicine (2010-),6th Department of Internal Medicine,Hygeia General Hospital of Athens, Greece,Head: Professor Helen Giamarellou
• First Department Of Medicine, Medical School, Laiko Hospital (2015-),Infectious Disease Fellow Head: Professor G. L. Daikos

Clinical Interest:

• Urinary tract infections and prostatitis
• Presenter at courses on Rational Antimicrobial Therapy for Community-acquired infections across the country under the auspices of the Hellenic Center for Disease Control and Prevention
• Presenter of Rational Antimicrobial Therapy for Hospital physicians in hospitals across the country under the auspices of the Hellenic Society of Chemotherapy.
• Presentations in Greek and International congresses on Infectious Diseases with topics covered: antibiotics, pharmacokinetics and dosage strategies. 

Research Interest:

• Urinary tract infections and prostatitis
• Pharmacokinetic studies of newer and older antibiotics 
• Nosocomial infections 
• Epidemiology surveillance studies 

• First Award for best abstract on Infectious Diseases at the 41st PanHellenic Medical Congress, Athens, Greece, June 2015
• First Award for best abstract on Clinical Research at the 41st PanHellenic Medical Congress, Athens, Greece, June 2015
• Best PhD award from the Hellenic Society for Infectious Disease for the best PhD on Infectious Diseases at the 15th Hellenic Congress for Infectious Diseases, Athens, May 2015 
• First Award for best abstract on Infectious Diseases at the 40th PanHellenic Medical Congress, Athens, Greece, May 2014
• First Award for best abstract on Infectious Diseases at the 38th PanHellenic Medical Congress, Athens, Greece, May 2012
• First Award for best abstract on Infectious Diseases at the 37th PanHellenic Medical Congress, Athens, Greece, May 2011

• Karaiskos I, Souli M, Giamarellou H. Plazomicin: an investigational therapy for the treatment of urinary tract infections. Expert Opinion on Investigational Drugs 2015;24(11):1501-11.
• Karaiskos I, Friberg LE, Pontikis K, Tsagkari V, Ioannidis K, Galani L, Baziaka F, Paskalis C, Koutsoukou A, Giamarellou H. Colistin Population Pharmacokinetics after Application of a Loading Dose of 9 MU Colistin Methanesulfonate (CMS) in Critically Ill Patients. Antimicrob Agents Chemother. 2015;59(12):7240-8.
• Karaiskos I, Giamarellou H. Multidrug-resistant and extensively drug-resistant Gram-negative pathogens: current and emerging therapeutic approaches. Expert Opin Pharmacother. 2014;15:1351-70.
• Pontikis K, Karaiskos I, Bastani S, Dimopoulos G, Kalogirou M, Katsiari M, Oikonomou A, Poulakou G, Roilides E, Giamarellou H. Outcomes of critically ill inten-sive care unit patients treated with fosfomycin for infections due to pandrug-resistant and extensively drug-resistant carbapenemase-producing Gram-negative bacteria. Int J Antimicrob Agents. 2014;43(1):52-9.
• Karaiskos I, Galani L, Baziaka F, Katsouda E, Ioannidis I, Andreou A, Paskalis H, Giamarellou H. Successful treatment of extensively drug-resistant Acinetobacter baumannii ventriculitis and meningitis with intraventricular colistin after application of a loading dose: a case series. Ιnt J Antimicrob Agents. 2013;41(5):480-3.
• Karaiskos I, Galani L, Baziaka F, Giamarellou H. Intraventricular and intrathecal col-istin as the last therapeutic resort for the treatment of multidrug-resistant and exten-sively drug-resistant Acinetobacter baumannii ventriculitis and meningitis: a literature review. Int J Antimicrob Agents. 2013;41(6):499-508.
• Giamarellou H, Galani L, Baziaka F, Karaiskos I. Effectiveness of a Double-Carbapenem Regimen for Infections in Humans Due to Carbapenemase-Producing Pandrug-Resistant Klebsiella pneumoniae. Antimicrob Agents Chemother. 2013;57(5):2388-90.
• Karvanen M., Plachouras D, Friberg LE, Paramythiotou E, Papadomichelakis E, Karaiskos I, Tsangaris I, Armaganidis A, Cars O, Giamarellou H. Colistin Me-thanesulphonate (CMS) and Colistin Pharmacokinetics in Critically Ill Patients Receiving Continuous Veno-venous Hemodiafiltration (CVVHDF). Antimicrob Agents Chemother. 2013; 57(1):668-71.
• Mohamed AF, Karaiskos I, Plachouras D, Karvanen M, Pontikis K, Jansson B, Papa-domicheakis E, Antoniadou A, Giamarellou H, Armaganidis ,Cars O, Friberg LE. Appli-cation of a Loading Dose of Colistin Methanesulphonate (CMS) in Critically Ill Patients: Population Pharmacokinetics, Protein Binding and Prediction of Bacterial Kill. Antimicrob Agents Chemother. 2012; 56(8):4241-9.
• Plachouras D, Karvanen M, Friberg LE, Papadomichelakis E, Antoniadou A, Tsangaris I, Karaiskos I, Poulakou G, Kontopidou F, Armaganidis A, Cars O, Giamarellou H.Population pharmacokinetic analysis of colistin methanesulfonate and colistin after intravenous administration in critically ill patients with infections caused by gram-negative bacteria. Antimicrob Agents Chemother. 2009; 53(8):3430-6.